Señales en vivo de CLSD | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:00):

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space...

Stats
Volumen de hoy	147 619
Volumen promedio	385 041
Capitalización de mercado	95.64M
EPS	$0 ( 2024-03-12 )
Próxima fecha de ganancias	( $-0.140 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.42
ATR14	$0.00500 (0.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Gibney Anthony S	Buy	93 290	Common Stock
2024-04-17	Gibney Anthony S	Buy	6 710	Common Stock
2024-04-15	Gibney Anthony S	Buy	45 000	Stock Option (right to buy)
2024-04-15	Gibney Anthony S	Buy	0
2024-03-20	Chong Ngai Hang Victor	Buy	30 000	Common Stock

INSIDER POWER
66.98
Last 97 transactions
Buy: 5 495 368 \| Sell: 2 175 231

Volumen Correlación

Largo: 0.17 (neutral)

Corto: 0.75 (moderate)

Signal:(60.483) Neutral

Clearside Biomedical Inc Correlación

10 Correlaciones Más Positivas
BNIXU	0.821
FULC	0.817
EDRY	0.808
GRNQ	0.805
AKRO	0.802
HOTH	0.802

10 Correlaciones Más Negativas
RMRM	-0.93
GOODM	-0.845

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Clearside Biomedical Inc Correlación - Moneda/Commodity

-0.04
( neutral )

-0.17
( neutral )

0.00
( neutral )

0.01
( neutral )

Clearside Biomedical Inc Finanzas

Annual	2023
Ingresos:	$8.23M
Beneficio Bruto:	$7.80M (94.87 %)
EPS:	$-0.530

FY	2023
Ingresos:	$8.23M
Beneficio Bruto:	$7.80M (94.87 %)
EPS:	$-0.530

FY	2022
Ingresos:	$1.33M
Beneficio Bruto:	$1.12M (84.63 %)
EPS:	$-0.570

FY	2021
Ingresos:	$29.58M
Beneficio Bruto:	$29.58M (100.00 %)
EPS:	$0.00632

Financial Reports:

No articles found.

Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Actualizaciones en tiempo real para Clearside Biomedical Inc [CLSD]

Upcoming Earnings Alert